33 Steven Cohen Biomarin Pharmaceutical - Registered Shares Trades
Steven Cohen acquired 266 Thousand Biomarin Pharmaceutical - Registered Shares shares worth $15.9 Million. That's 0.05% of their equity portfolio (383rd largest holding). The first Biomarin Pharmaceutical - Registered Shares trade was made in Q2 2014.
Since then Steven Cohen bought shares twenty more times and sold shares on eighteen occasions. The investor's estimated purchase price is $21.1 Million, resulting in a loss of 25%.
Avg closing price
Price range
News about Biomarin Pharmaceutical Inc. - Registered Shares and Steven Cohen
Hedge Fund and Insider Trading News: Carl Icahn, Steve Cohen, Ray Dalio, Balyasny Asset Management, Elliott Management, Coatue Management, American Water Works Company Inc (AWK), Life Time Group Holdings, Inc (LTH), and More
Icahn’s Investment Fund Plunges Deeper Into the Red (Institutional Investor) Steve Cohen’s Latest Donations Support Student-Managed Funds (Observer.com) Acti...
Insider Monkey,
over 1 year
ago